Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5202232
Max Phase: Preclinical
Molecular Formula: C62H63N7O8
Molecular Weight: 1034.23
Associated Items:
ID: ALA5202232
Max Phase: Preclinical
Molecular Formula: C62H63N7O8
Molecular Weight: 1034.23
Associated Items:
Canonical SMILES: CCc1c(C)c2cc3nc(cc4nc(c5c6[nH]c(cc1[nH]2)c(C)c6C(=O)C5)[C@@H](CCC(=O)OC)[C@@H]4C)C(C)=C3COCc1cccc(C#Cc2cccc(Nc3ncnc4cc(OCCOC)c(OCCOC)cc34)c2)c1
Standard InChI: InChI=1S/C62H63N7O8/c1-9-43-35(2)49-29-54-47(37(4)48(67-54)28-50-36(3)44(18-19-58(71)74-8)60(68-50)46-26-55(70)59-38(5)51(69-61(46)59)30-53(43)66-49)33-75-32-41-14-10-12-39(24-41)16-17-40-13-11-15-42(25-40)65-62-45-27-56(76-22-20-72-6)57(77-23-21-73-7)31-52(45)63-34-64-62/h10-15,24-25,27-31,34,36,44,66,69H,9,18-23,26,32-33H2,1-8H3,(H,63,64,65)/b48-28-,49-29-,50-28-,51-30-,53-30-,54-29-,60-46-/t36-,44-/m0/s1
Standard InChI Key: HYIZARGDJNDVOK-ZVVOHXGHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1034.23 | Molecular Weight (Monoisotopic): 1033.4738 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Otvagin VF, Kuzmina NS, Kudriashova ES, Nyuchev AV, Gavryushin AE, Fedorov AY.. (2022) Conjugates of Porphyrinoid-Based Photosensitizers with Cytotoxic Drugs: Current Progress and Future Directions toward Selective Photodynamic Therapy., 65 (3.0): [PMID:35050607] [10.1021/acs.jmedchem.1c01953] |
Source(1):